KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Total Debt (2016 - 2025)

Charles River Laboratories International has reported Total Debt over the past 17 years, most recently at $2.1 billion for Q4 2025.

  • For Q4 2025, Total Debt fell 4.64% year-over-year to $2.1 billion; the TTM value through Dec 2025 reached $2.1 billion, down 4.64%, while the annual FY2025 figure was $2.1 billion, 4.64% down from the prior year.
  • Total Debt for Q4 2025 was $2.1 billion at Charles River Laboratories International, down from $2.2 billion in the prior quarter.
  • Over five years, Total Debt peaked at $3.0 billion in Q2 2022 and troughed at $2.1 billion in Q4 2025.
  • A 5-year average of $2.6 billion and a median of $2.7 billion in 2023 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: surged 34.68% in 2021 and later decreased 15.37% in 2024.
  • Year by year, Total Debt stood at $2.7 billion in 2021, then grew by 1.54% to $2.7 billion in 2022, then fell by 2.23% to $2.6 billion in 2023, then decreased by 15.37% to $2.2 billion in 2024, then decreased by 4.64% to $2.1 billion in 2025.
  • Business Quant data shows Total Debt for CRL at $2.1 billion in Q4 2025, $2.2 billion in Q3 2025, and $2.3 billion in Q2 2025.